½ÃÀ庸°í¼­
»óǰÄÚµå
1571026

À¯·´ÀÇ ºñ´¢±â°ú ±â±â ½ÃÀå : ½ÃÀå ±Ô¸ð, µ¿Çâ ¹× ºÐ¼®(2025-2031³â) : MedSuite

Urology Market Size, Share & Trends Analysis | Europe | 2025-2031 | MedSuite | Includes: Urinary Catheters, Urinary Incontinence Slings, and 7 more

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: iData Research Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 664 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

2024³â À¯·´ ºñ´¢±â°ú Àåºñ ½ÃÀå ±Ô¸ð´Â 21¾ï À¯·Î ÀÌ»óÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº CAGR 3.7%·Î ¼ºÀåÇßÀ¸¸ç 2031³â¿¡´Â 27¾ï À¯·Î ÀÌ»ó¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯·´ÀÇ ºñ´¢±â°ú Àåºñ ½ÃÀåÀÌ È®¸³µÇ¾î Àֱ⠶§¹®¿¡ Å« ¼ºÀå ±âȸ´Â Á¦ÇѵǾî ÀÖ½À´Ï´Ù. °¢ ȸ»ç´Â °è¼Ó ½ÅÁ¦Ç°À» ÅõÀÔÇϰí ÀÖÁö¸¸ ÀϺΠ±¹°¡¿¡¼­´Â »óȯÀÌ Á¦ÇѵǾî ÀÖÀ¸¸ç Áö¿ª Àüü¿¡¼­ °¡°Ý ¾Ð·ÂÀÌ °¡ÇØÁ® ´ëºÎºÐÀÇ ºÎ¹®¿¡¼­ Æò±Õ ÆÇ¸Å °¡°Ý(ASP)ÀÌ ÆòÆòÇØÁö°í ÀÖ½À´Ï´Ù.

Coloplast´Â ¿äµµ Ä«Å×ÅÍ, ¿äµµ °¡À̵å¿ÍÀ̾î, ³²¼º¿ë »ý½Ä ÀÇ·á±â±â ºÐ¾ß¿¡¼­ ½ÃÀåÀ» ¼±µµÇßÀ¸¸ç °á¼® °ü¸®, ½Å·ç Á¶¼³ ¹× ¿ä½Ç±Ý Àåºñ¿¡¼­µµ Á¸Àç°¨À» º¸¿´½À´Ï´Ù.

Becton DickinsonÀº ¿ä½Ç±Ý ½ÃÀåÀ» µ¶Á¡ÇÏ°í ´Ù¸¥ ÀϺΠºÎ¹®¿¡¼­µµ Á¡À¯À²À» À¯ÁöÇÕ´Ï´Ù.

±âŸ ÁÖ¿ä ±â¾÷À¸·Î´Â Wellspect HealthCare, Boston Scientific, Hollister Inc µîÀÌ ÀÖ½À´Ï´Ù. Boston ScientificÀº 4°³ ºÎ¹®¿¡¼­ ¼±µÎ¸¦ Â÷ÁöÇßÁö¸¸ ¿äµµ Ä«Å×ÅÍ ½ÃÀå¿¡ ÁøÃâÇÏÁö ¾Ê¾ÒÀ¸¸ç Àüü ½ÃÀå Á¡À¯À²Àº Á¦ÇÑÀûÀ̾ú½À´Ï´Ù.

ÀÌ º¸°í¼­´Â À¯·´ÀÇ ºñ´¢±â°ú Àåºñ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ºÎ¹®º° µ¿Çâ, COVID-19ÀÇ ¿µÇ⠺м®, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, °æÀï ½ÃÀå Á¡À¯À² ºÐ¼® ¹× ½ÃÀå ÁøÃâ ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¶»ç ¹æ¹ý

À¯·´ÀÇ ºñ´¢±â°ú Àåºñ ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

  • ¼Ò°³
  • Áö¿ª ÇÁ·ÎÆÄÀÏ
  • ½ÃÀå ºÎ¹®º° ºÐ¼®
    • ¿ö½ºÆ® ÄÉÀ̽º ½Ã³ª¸®¿À
    • º£À̽º ÄÉÀ̽º ½Ã³ª¸®¿À
    • º£½ºÆ® ÄÉÀ̽º ½Ã³ª¸®¿À

Áúº´ °³¿ä

  • ±âº»ÀûÀÎ ÇØºÎÇÐ
  • Áúº´ÀÇ Ä¡·á¿Í Áø´Ü
  • ȯÀÚ Àα¸Åë°è

Á¦Ç° Æò°¡

  • ¼Ò°³
  • Á¦Ç° Æ÷Æ®Æú¸®¿À
  • ±ÔÁ¦»óÀÇ ¹®Á¦¿Í ¸®ÄÝ
  • ÀÓ»ó½ÃÇè

À¯·´ÀÇ ºñ´¢±â°ú Àåºñ ½ÃÀå °³¿ä

  • ¼Ò°³
  • ȯÀ²
  • ½ÃÀå °³¿ä¿Í Æ®·»µå ºÐ¼®
  • ¼ºÀå ÃËÁø¿äÀΰú ÀúÇØ¿äÀÎ
  • °æÀï ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÇÕº´°ú Àμö
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Becton Dickinson
    • Boston Scientific
    • Cardinal Health
    • Coloplast
    • Cook Medical
    • Elekta
    • Ethicon
    • Karl Storz
    • Laborie
    • Medline
    • Olympus
    • Siemens Healthineers
    • Teleflex
  • SWOT ºÐ¼®

±¹°¡º° ÇÁ·ÎÆÄÀÏ

  • ¼Ò°³
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ¿µ±¹
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • º£³×·è½º
  • ½ºÄ­µð³ªºñ¾Æ
  • ¿À½ºÆ®¸®¾Æ
  • ½ºÀ§½º
  • Æ÷¸£Åõ°¥

¼ö±â °Ç¼ö

¿äµµ Ä«Å×ÅÍ ½ÃÀå

  • ¼Ò°³
  • ½ÃÀå °³¿ä
  • ½ÃÀå ºÐ¼®°ú ¿¹Ãø
  • ¼ºÀå ÃËÁø¿äÀΰú ÀúÇØ¿äÀÎ
  • °æÀï ½ÃÀå Á¡À¯À² ºÐ¼®

¿ä½Ç±Ý ÀåÄ¡ ½ÃÀå

°á¼® °ü¸® Àåºñ ½ÃÀå

BPH Ä¡·á Àåºñ ½ÃÀå

ºñ´¢±â ³»½Ã°æ ½ÃÀå

Àú¼±·® ¹æ»ç¼± Ä¡·á Àåºñ ½ÃÀå

³²¼º »ý½Ä ÀÇ·á±â±â ½ÃÀå

¼Òº¯ °¡À̵å¿ÍÀÌ¾î ½ÃÀå

JHS 24.10.24

In 2024, the European market for urological devices was valued at over €2.1 billion. This market is projected to grow at a compound annual growth rate (CAGR) of 3.7%, reaching more than €2.7 billion by 2031. The comprehensive report on the European urological device market covers the following segments: urinary catheters, urinary incontinence devices, stone management devices, benign prostatic hyperplasia (BPH) treatment devices, urological endoscopes, low-dose radiation (LDR) brachytherapy devices, nephrostomy devices, men's reproductive health devices, and urinary guidewires.

MARKET DATA HIGHLIGHTS:

  • Unit sales, average selling prices, market size, and growth trends
  • Procedure volumes
  • Market drivers and constraints
  • Forecasts through 2031 and historical data back to 2021
  • Mergers & acquisitions
  • Company profiles and product portfolios
  • Key competitors

EUROPE UROLOGICAL DEVICE MARKET INSIGHTS

The European urological device market is well-established, which limits significant growth opportunities. Although companies continue to introduce new product adaptations, most segments face flat average selling prices (ASP) due to limited reimbursement in certain countries and pricing pressures across the region.

MARKET SHARE INSIGHTS (2024)

Coloplast led the market in the urinary catheter, urinary guidewire, and men's reproductive health device segments and had a notable presence in stone management, nephrostomy, and urinary incontinence devices.

Becton Dickinson was the second-leading competitor, dominating the urinary incontinence market and maintaining shares across several other segments.

Other top players included Wellspect HealthCare, Boston Scientific, and Hollister Inc. Although Boston Scientific led four segments, its absence in the urinary catheter market limited its overall market share.

MARKET SEGMENTATION SUMMARY

  • Urinary Catheter Market: Segmented by device type-Intermittent, Foley, and External (Male, Female).
  • Urinary Incontinence Device Market: Segmented by modality-Urethral Bulking Agents, Female Incontinence Slings, Male Implantable Devices, and Urinary Bags.
  • Stone Management Device Market: Segmented by device type-ESWL Equipment, Laser, Retrieval Devices, Ureteral Stents, and Access Sheaths.
  • BPH Treatment Device Market: Segmented by device type-TURP, Laser BPH, UroLift(R), and Rezum(R).
  • Urological Endoscope Market: Segmented by device type-Single-use, Rigid, and Flexible Cystoscopes; Single-use, Semi-rigid, and Flexible Ureteroscopes; Rigid Resectoscopes; and Rigid Nephroscopes.
  • Low-Dose Radiation (LDR) Brachytherapy Device Market: Segmented by device type-Needles and Brachytherapy Iodine Seeds.
  • Nephrostomy Device Market: Segmented by device type-Percutaneous Nephrostomy Sets, Nephrostomy Balloon Catheters, and Nephrostomy Drainage Tubes.
  • Men's Reproductive Health Market: Segmented by device type-Inflatable Erectile Dysfunction Devices and Malleable Erectile Dysfunction Devices.
  • Urinary Guidewire Market: Covers all guidewires used in urological procedures.

RESEARCH SCOPE SUMMARY

  • Region: Europe (France, U.K., Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, Portugal)
  • Base Year: 2024
  • Forecast: 2025-2031
  • Historical Data: 2021-2023
  • Quantitative Coverage: Procedure numbers, market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
  • Qualitative Coverage: COVID-19 impact, market growth trends, market constraints, competitive analysis, SWOT analysis, mergers & acquisitions, company profiles, and product portfolios.
  • Data Sources: Primary interviews with industry leaders, government physician data, regulatory data, hospital private data, import/export data, iData Research's internal database.

TABLE OF CONTENT

TABLE of CONTENTS

List of Figures

List of Charts

executive summary

European Urological Device Market Overview

Competitive Analysis

Emerging Markets and Technologies

Market Developments

Market Trends

Market Segmentation

Procedure Segmentation

Key Report Updates

Version History

research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE European Urological Device Market

  • 2.1 Introduction
  • 2.2 Country Profiles
  • 2.3 Analysis By Market Segment
    • 2.3.1 Worst Case Scenario
    • 2.3.2 Base Case Scenario
    • 2.3.3 Best Case Scenario

Disease overview

  • 3.1 Basic Anatomy
    • 3.1.1 Urinary System
      • 3.1.1.1 Male Urinary System
      • 3.1.1.2 Female Urinary System
  • 3.2 Disease Treatment and Diagnostics
    • 3.2.1 Benign Prostatic Hyperplasia
    • 3.2.2 Urinary Incontinence
    • 3.2.3 Urinary Tract Infections
    • 3.2.4 Kidney Stones
    • 3.2.5 Bladder Prolapse
    • 3.2.6 Overactive Bladder
    • 3.2.7 Prostatitis
    • 3.2.8 Men's Reproductive Health
    • 3.2.9 Cancer
      • 3.2.9.1 Prostate Cancer
      • 3.2.9.2 Bladder Cancer
  • 3.3 Patient Demographics
    • 3.3.1 Benign Prostatic Hyperplasia
    • 3.3.2 Urinary Incontinence
    • 3.3.3 Urinary Tract Infections
    • 3.3.4 Kidney Stones
    • 3.3.5 Bladder Prolapse
    • 3.3.6 Overactive Bladder
    • 3.3.7 Prostatitis
    • 3.3.8 Men's Reproductive Health
    • 3.3.9 Cancer
      • 3.3.9.1 Prostate Cancer
      • 3.3.9.2 Bladder Cancer

Product Assessment

  • 4.1 Introduction
  • 4.2 Product Portfolios
    • 4.2.1 Urinary Incontinence
      • 4.2.1.1 Urinary Catheters
      • 4.2.1.2 Urethral Bulking Agents
      • 4.2.1.3 Female Incontinence Slings
      • 4.2.1.4 Male Implantable Devices
      • 4.2.1.5 Urine Bags
    • 4.2.2 Stone Management
      • 4.2.2.1 ESWL Equipment
      • 4.2.2.2 Intracorporeal Lithotripsy Equipment
      • 4.2.2.3 Holmium Lasers
      • 4.2.2.4 Stone Fragment Retrieval Devices
      • 4.2.2.5 Ureteral Stents
      • 4.2.2.6 Thulium Lasers and Fibers
    • 4.2.3 BPH Treatment
      • 4.2.3.1 TURP
      • 4.2.3.2 TUMT
      • 4.2.3.3 TUNA
      • 4.2.3.4 Prostatic Stents
      • 4.2.3.5 Novel BPH Solutions
      • 4.2.3.6 Laser BPH
    • 4.2.4 Urological Endoscopes
      • 4.2.4.1 Cystoscopes
      • 4.2.4.2 Ureteroscopes
      • 4.2.4.3 Resectoscopes
      • 4.2.4.4 Nephroscopes
    • 4.2.5 Nephrostomy
      • 4.2.5.1 Percutaneous Nephrostomy Drainage Tubes & Sets
      • 4.2.5.2 Nephrostomy Balloon Catheters
    • 4.2.6 Men's Reproductive Health
      • 4.2.6.1 Penile Implants
      • 4.2.6.2 Testicular Implants
    • 4.2.7 Urinary Guidewires
  • 4.3 Regulatory Issues and Recalls
    • 4.3.1 Urinary Incontinence Device Market FDA Recalls
    • 4.3.2 Stone Management Device Market FDA Recalls
    • 4.3.3 BPH Treatment Device Market FDA Recalls
    • 4.3.4 Urological Endoscope Market FDA Recalls
    • 4.3.5 Nephrostomy Device Market FDA Recalls
    • 4.3.6 Men's Reproductive Health Device Market FDA Recalls
  • 4.4 Clinical Trials
    • 4.4.1 Urinary Incontinence Device Market Clinical Trials
    • 4.4.2 Stone Management Devices Market Clinical Trials
    • 4.4.3 BPH Treatment Device Market Clinical Trials
    • 4.4.4 Urological Endoscope Market Clinical Trials
    • 4.4.5 Men's Reproductive Health Device Market Clinical Trials

European Urological Device Market Overview

  • 5.1 Introduction
  • 5.2 Currency Exchange Rate
  • 5.3 Market Overview & Trend Analysis
  • 5.4 Drivers and Limiters
    • 5.4.1 Market Drivers
    • 5.4.2 Market Limiters
  • 5.5 Competitive Market Share Analysis
  • 5.6 Mergers and Acquisitions
  • 5.7 Company Profiles
    • 5.7.1 Becton Dickinson
    • 5.7.2 Boston Scientific
    • 5.7.3 Cardinal Health
    • 5.7.4 Coloplast
    • 5.7.5 Cook Medical
    • 5.7.6 Elekta
    • 5.7.7 Ethicon
    • 5.7.8 Karl Storz
    • 5.7.9 Laborie
    • 5.7.10 Medline
    • 5.7.11 Olympus
    • 5.7.12 Siemens Healthineers
    • 5.7.13 Teleflex
  • 5.8 SWOT Analysis
    • 5.8.1 Becton Dickinson
    • 5.8.2 Boston Scientific
    • 5.8.3 Cardinal Health
    • 5.8.4 Coloplast
    • 5.8.5 Cook Medical
    • 5.8.6 Elekta
    • 5.8.7 Ethicon
    • 5.8.8 Karl Storz
    • 5.8.9 Laborie
    • 5.8.10 Medline
    • 5.8.11 Olympus
    • 5.8.12 Siemens Healthineers
    • 5.8.13 Teleflex

Country Profiles

  • 6.1 Introduction
    • 6.1.1 Population
    • 6.1.2 GDP Per Capita
    • 6.1.3 Price Index
  • 6.2 Germany
  • 6.3 France
  • 6.4 United Kingdom
  • 6.5 Italy
  • 6.6 Spain
  • 6.7 Benelux
  • 6.8 Scandinavia
  • 6.9 Austria
  • 6.10 Switzerland
  • 6.11 Portugal

Procedure Numbers

  • 7.1 Procedures
  • 7.2 Prostate Cancer Treatment Procedures
    • 7.2.1 Open Prostatectomy Procedures
    • 7.2.2 Laparoscopic Prostatectomy Procedures
    • 7.2.3 Robotic Prostatectomy Procedures
    • 7.2.4 Watchful Waiting Procedures
    • 7.2.5 HIFU Procedures
    • 7.2.6 Brachytherapy Procedures
    • 7.2.7 High-Dose Radiation Procedures
    • 7.2.8 External Radiation Therapy (Primary) Procedures
    • 7.2.9 External Radiation Therapy (Secondary) Procedures
  • 7.3 Interventional BPH Procedures
    • 7.3.1 TURP Procedures
      • 7.3.1.1 Monopolar Electrode TURP Procedures
      • 7.3.1.2 Bipolar Electrode TURP Procedures
    • 7.3.2 Laser BPH Procedures
    • 7.3.3 Urolift Procedures
    • 7.3.4 Rezum Procedures
  • 7.4 Stone Management Procedures
    • 7.4.1 ESWL Procedures
    • 7.4.2 Stone Management Holmium Laser Procedures
    • 7.4.3 PCNL Procedures
    • 7.4.4 Ureteral Stent Placement Procedures
  • 7.5 Nephrostomy Procedures
  • 7.6 Urinary Incontinence Procedures
    • 7.6.1 Male Urinary Incontinence Procedures
      • 7.6.1.1 Male Incontinence Sling Procedures
      • 7.6.1.2 Male Incontinence Sling Removal Procedures
      • 7.6.1.3 Male Urinary Artificial Sphincter Procedures
    • 7.6.2 Female Urinary Incontinence Procedures
      • 7.6.2.1 Transvaginal Tape Incontinence Sling Procedures
      • 7.6.2.2 Transobturator Incontinence Sling Procedures
      • 7.6.2.3 Single-Incision Incontinence Sling Procedures
      • 7.6.2.4 Incontinence Sling Removal Procedures
      • 7.6.2.5 Urethral Suspension Procedures
  • 7.7 Erectile Dysfunction Management Procedures
    • 7.7.1 Total Erectile Dysfunction Management Procedures
      • 7.7.1.1 Inflatable Implant Procedures
      • 7.7.1.2 Malleable Implant Procedures

Urinary Catheter Market

  • 8.1 Introduction
  • 8.2 Market Overview
  • 8.3 Market Analysis and Forecast
    • 8.3.1 Total Urinary Catheter Market
    • 8.3.2 Intermittent Urinary Catheter Market
    • 8.3.3 Foley Catheter Market
    • 8.3.4 External Catheter Market
      • 8.3.4.1 Male External Catheter Market
      • 8.3.4.2 Female External Catheter Market
  • 8.4 Drivers and Limiters
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 Competitive Market Share Analysis

Urinary Incontinence Device Market

  • 9.1 Introduction
  • 9.2 Market Overview
  • 9.3 Market Analysis and Forecast
    • 9.3.1 Urethral Bulking Agent Market
    • 9.3.2 Female Urinary Incontinence Sling Market
      • 9.3.2.1.1 Transvaginal Tape Female Incontinence Sling Market
      • 9.3.2.1.2 Transobturator Female Incontinence Sling Market
      • 9.3.2.1.3 Single-Incision Female Incontinence Sling Market
    • 9.3.3 Male Implantable Device Market
      • 9.3.3.1 Total Male Implantable Device Market
      • 9.3.3.2 Male Urinary Incontinence Sling Market
      • 9.3.3.3 Male Artificial Urinary Sphincter Market
    • 9.3.4 Urinary Bag Market
      • 9.3.4.1 Total Urinary Bag Market
      • 9.3.4.2 Bedside Urinary Bag Market
      • 9.3.4.3 Leg Urinary Bag Market
  • 9.4 Drivers and Limiters
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 Competitive Market Share Analysis

Stone Management Device Market

  • 10.1 Introduction
  • 10.2 Market Overview
  • 10.3 Market Analysis and Forecast
    • 10.3.1 ESWL Equipment Market
    • 10.3.2 Stone Management Laser Market
      • 10.3.2.1 Holmium Stone Management Laser Market
      • 10.3.2.1.1 Holmium Stone Management Laser Capital Equipment Market
      • 10.3.2.1.2 Holmium Stone Management Laser Fiber Market
      • 10.3.2.2 Thulium Stone Management Laser Market
      • 10.3.2.2.1 Thulium Stone Management Laser Capital Equipment Market
      • 10.3.2.2.2 Thulium Stone Management Laser Fiber Market
    • 10.3.3 Stone Fragment Retrieval Device Market
      • 10.3.3.1 Nitinol Stone Fragment Retrieval Device Market
      • 10.3.3.1.1 Nitinol Basket Stone Fragment Retrieval Device Market
      • 10.3.3.1.2 Nitinol Grasper Stone Fragment Retrieval Device Market
      • 10.3.3.2 Stainless-Steel Stone Fragment Retrieval Device Market
      • 10.3.3.2.1 Stainless-Steel Basket Stone Fragment Retrieval Device Market
      • 10.3.3.2.2 Stainless-Steel Grasper Stone Fragment Retrieval Device Market
    • 10.3.4 Ureteral Stent Market
    • 10.3.5 Access Sheath Market
  • 10.4 Drivers and Limiters
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 Competitive Market Share Analysis

BPH Treatment Device Market

  • 11.1 Introduction
  • 11.2 Market Overview
  • 11.3 Market Analysis and Forecast
    • 11.3.1 TURP Market
      • 11.3.1.1 Monopolar Electrode Market
      • 11.3.1.2 Bipolar Electrode Market
    • 11.3.2 Laser BPH Market
      • 11.3.2.1 Holmium Laser BPH Market
      • 11.3.2.1.1 Holmium Laser BPH Capital Equipment Market
      • 11.3.2.1.2 Holmium Laser BPH Fiber Market
      • 11.3.2.2 Thulium Laser BPH Market
      • 11.3.2.2.1 Thulium Laser BPH Capital Equipment Market
      • 11.3.2.2.2 Thulium Laser BPH Fiber Market
    • 11.3.3 UroLift Market
    • 11.3.4 Rezum Market
      • 11.3.4.1 Rezum Equipment Market
      • 11.3.4.2 Rezum Consumables Market
  • 11.4 Drivers and Limiters
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 Competitive Market Share Analysis

Urological Endoscope Market

  • 12.1 Introduction
  • 12.2 Market Overview
  • 12.3 Market Analysis and Forecast
    • 12.3.1 Total Urological Endoscope Market
    • 12.3.2 Cystoscope Market
      • 12.3.2.1 Single-Use Cystoscope Market
      • 12.3.2.2 Rigid Cystoscope Market
      • 12.3.2.3 Flexible Cystoscope Market
      • 12.3.2.3.1 Flexible Fiber Optic Cystoscope Market
      • 12.3.2.3.2 Flexible Video Cystoscope Market
    • 12.3.3 Ureteroscope Market
      • 12.3.3.1 Single-Use Ureteroscope Market
      • 12.3.3.2 Semi-Rigid Ureteroscope Market
      • 12.3.3.3 Flexible Ureteroscope Market
      • 12.3.3.3.1 Flexible Fiber Optic Ureteroscope Market
      • 12.3.3.3.2 Flexible Video Ureteroscope Market
    • 12.3.4 Resectoscope Market
    • 12.3.5 Nephroscope Market
  • 12.4 Drivers and Limiters
    • 12.4.1 Market Drivers
    • 12.4.2 Market Limiters
  • 12.5 Competitive Market Share Analysis

Low-Dose Radiation Brachytherapy Device Market

  • 13.1 Introduction
  • 13.2 Market Analysis and Forecast
    • 13.2.1 LDR Needle Market
    • 13.2.2 LDR Brachytherapy Iodine Seed Market
  • 13.3 Drivers and Limiters
    • 13.3.1 Market Drivers
    • 13.3.2 Market Limiters
  • 13.4 Competitive Market Share Analysis

Nephrostomy Device Market

  • 14.1 Introduction
  • 14.2 Market Overview
  • 14.3 Market Analysis and Forecast
    • 14.3.1 Percutaneous Nephrostomy Set Market
    • 14.3.2 Nephrostomy Balloon Catheter Market
    • 14.3.3 Nephrostomy Drainage Tube Market
  • 14.4 Drivers and Limiters
    • 14.4.1 Market Drivers
    • 14.4.2 Market Limiters
  • 14.5 Competitive Market Share Analysis

Men's reproductive health Device Market

  • 15.1 Introduction
  • 15.2 Market Overview
  • 15.3 Market Analysis and Forecast
    • 15.3.1 Total Men's Reproductive Health Device Market
    • 15.3.2 Inflatable Erectile Dysfunction Device Market
    • 15.3.3 Malleable Erectile Dysfunction Device Market
  • 15.4 Drivers and Limiters
    • 15.4.1 Market Drivers
    • 15.4.2 Market Limiters
  • 15.5 Competitive Market Share Analysis

Urinary Guidewire Market

  • 16.1 Introduction
  • 16.2 Market Analysis and Forecast
  • 16.3 Drivers and Limiters
    • 16.3.1 Market Drivers
    • 16.3.2 Market Limiters
  • 16.4 Competitive Market Share Analysis

Abbreviations

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦